Charles Jobson Acquires 127,676 Shares of Joint (NASDAQ:JYNT) Stock

The Joint Corp. (NASDAQ:JYNT) major shareholder Charles Jobson acquired 127,676 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were acquired at an average cost of $8.57 per share, with a total value of $1,094,183.32. Following the purchase, the insider directly owned 1,773,479 shares of the company’s stock, valued at $15,198,715.03. This trade represents a 7.76% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Joint Stock Performance

NASDAQ:JYNT opened at $8.23 on Friday. The firm has a market capitalization of $117.36 million, a price-to-earnings ratio of 35.78 and a beta of 1.11. The Joint Corp. has a 52-week low of $7.50 and a 52-week high of $13.47. The stock has a fifty day moving average of $8.66 and a 200 day moving average of $8.81.

Joint (NASDAQ:JYNT) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.05. The company had revenue of $14.82 million during the quarter, compared to analyst estimates of $14.50 million. Joint had a return on equity of 7.00% and a net margin of 5.72%. Equities analysts forecast that The Joint Corp. will post 0.51 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Joint

Hedge funds and other institutional investors have recently modified their holdings of the stock. JCP Investment Management LLC lifted its stake in shares of Joint by 24.0% in the 3rd quarter. JCP Investment Management LLC now owns 593,906 shares of the company’s stock valued at $5,666,000 after acquiring an additional 115,062 shares during the last quarter. Skylands Capital LLC lifted its stake in shares of Joint by 6.9% in the 4th quarter. Skylands Capital LLC now owns 890,045 shares of the company’s stock valued at $7,761,000 after acquiring an additional 57,767 shares during the last quarter. Verus Capital Partners LLC lifted its stake in shares of Joint by 1.7% in the 3rd quarter. Verus Capital Partners LLC now owns 113,426 shares of the company’s stock valued at $1,082,000 after acquiring an additional 1,947 shares during the last quarter. Stoneridge Investment Partners LLC bought a new stake in shares of Joint in the 3rd quarter valued at about $117,000. Finally, XTX Topco Ltd bought a new stake in shares of Joint in the 4th quarter valued at about $124,000. Institutional investors own 76.88% of the company’s stock.

Analyst Ratings Changes

JYNT has been the subject of several research analyst reports. Zacks Research raised Joint from a “hold” rating to a “strong-buy” rating in a research note on Tuesday. Wall Street Zen raised Joint from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, Weiss Ratings lowered Joint from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday, May 6th. One research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $18.00.

About Joint

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.